Dr Reddy's to scale-up of ops in the U.S.; GSK hopes for more from HGS collaboration;

@FiercePharma: GSK, Human Genome gear up for Benlysta launch. Report | Follow @FiercePharma 

> Dr Reddy's Laboratories is set for a significant scale-up of its operations in the U.S., including developing partnerships with other firms and a possible rebuilding of its research presence in this critical market. Article

> After waiting 18 years for its partnership with Human Genome Sciences to bear fruit, drug giant GlaxoSmithKline hopes the FDA approval of a new lupus treatment is just the first in a string of products springing from the collaboration. Story

> A long-running attempt to make it easier to produce and distribute copies of patented medicines for sale at cut-rate prices to the world's poorest countries has been approved by the House of Commons. News

> Mylan subsidiary Matrix Laboratories Limited has received final approval from the FDA under the President's Emergency Plan for AIDS Relief for its application for zidovudine tablets, 100 mg. Mylan release

> The early end of James Marshall's career, blamed by the actor and musician on Roche's Accutane acne drug, was an "unbelievable tragedy," former co- star Brian Dennehy said in court. Story

> Eli Lilly said Dr. Greg Plowman will become the vice president of oncology research and senior vice president of ImClone Systems research March 28. Report

> AstraZeneca has bought back 228,781 ordinary shares at 2972p apiece for cancellation. News

> Twelve parallel imported products from OPD Laboratories, Caseview and Delta Pharma have been recalled by UK regulators because of problems with patient information leaflets. Item

Biotech News

@FierceBiotech: FDA hands GSK, Human Genome Sciences landmark Benlysta approval. Story | Follow @FierceBiotech

@JohnCFierce: Epizyme gets $6M upfront/$200M milestone deal in new discovery pact with Eisai. Report | Follow @JohnCFierce

> Sanofi, Regeneron's aflibercept flunks PhIII trial. Report

> Rock Spring Ventures aims for $100M fund. News 

> Vertex's epilepsy drug headed for larger study. Story

> ThromboGenics prepares for future FDA approval filing. Item 

And Finally... About one in every 20 adults in the U.S. has survived cancer, including nearly one-fifth of all people over 65, according to new federal data, suggesting that many forms of the disease are treatable. Report